DOI:
10.1055/s-00000019
Fortschritte der Neurologie · Psychiatrie
Issue 05 ·
Volume 71 ·
May 2003
DOI: 10.1055/s-002-2563
Editorial
229
Wallesch, C.-W.:
DRGs in Neurology and Psychiatry - Progress or Risk?
232
Klosterkötter, J.:
DRGs and Psych-PV
Originalarbeit
234
Andreas, S.;
Dirmaier, J.;
Koch, U.;
Schulz, H.:
On the Development of a Case Group Concept for Patients with Mental Diseases
243
Deisenhammer, E. A.;
Hinterhuber, H.:
Placebo-Controlled Antidepressant Drug Trials
249
Pajonk, F.-G.;
Schreiner, A.;
Peters, S.;
Rettig, K.;
Degner, D.;
Rüther, E.:
Initial Use of Risperidone in the Treatment of Acutely Exacerbated Schizophrenic Patients - An Interim Analysis
255
Dietrich, D. E.;
Kropp, S.;
Emrich, H. M.:
Oxcarbazepine in the Treatment of Affective and Schizoaffective Disorders
265
Schildmann, J.;
Bauer, A.;
Tilmann, Amely;
Vollmann, J.:
Patients' Perspective on the Quality of Informed Consent into Psychopharmacological Treatment in Schizophrenia and Depression
271
Shambal, S.;
Grehl, H.;
Zierz, S.;
Lindner, A.:
Age Dependence of Doppler Parameters in the Basal Cerebral Arteries Evaluated by Transcranial Color-Coded Duplexsonography